| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 501 | 02196 | 复星医药 | Credit Suisse Group AG |
减持 | -183.49万 | 2114.49万 | 5.24% | 2017-02-07 |
| 502 | 02196 | 复星医药 | Credit Suisse Group AG |
减持 | -205.49万 | 1818.55万 | 4.51% | 2017-02-07 |
| 503 | 02196 | 复星医药 | The Capital Group Companies, Inc. |
减持 | -51.65万 | 4835.60万 | 11.99% | 2017-02-02 |
| 504 | 02196 | 复星医药 | Credit Suisse Group AG |
增持 | 82.05万 | 2344.35万 | 5.81% | 2017-02-01 |
| 505 | 02196 | 复星医药 | Credit Suisse Group AG |
增持 | 77.55万 | 2079.71万 | 5.16% | 2017-02-01 |
| 506 | 02196 | 复星医药 | Wellington Management Group LLP |
增持 | 4.00万 | 2421.09万 | 6.00% | 2017-01-26 |
| 507 | 02196 | 复星医药 | Credit Suisse Group AG |
增持 | 43.81万 | 2048.85万 | 5.08% | 2017-01-20 |
| 508 | 02196 | 复星医药 | Credit Suisse Group AG |
减持 | -58.15万 | 2006.48万 | 4.98% | 2017-01-13 |
| 509 | 02196 | 复星医药 | Wellington Management Group LLP |
减持 | -3.00万 | 2416.99万 | 5.99% | 2017-01-13 |
| 510 | 02196 | 复星医药 | Credit Suisse Group AG |
增持 | 60.45万 | 2065.53万 | 5.12% | 2017-01-11 |
| 511 | 02196 | 复星医药 | EARNEST Partners, LLC |
增持 | 215.40万 | 2575.40万 | 6.39% | 2017-01-10 |
| 512 | 02196 | 复星医药 | Credit Suisse Group AG |
减持 | -15.26万 | 2003.24万 | 4.97% | 2017-01-05 |
| 513 | 02196 | 复星医药 | Wellington Management Group LLP |
增持 | 111.75万 | 2419.99万 | 6.00% | 2017-01-04 |
| 514 | 02196 | 复星医药 | Credit Suisse Group AG |
减持 | -445.40万 | 2024.45万 | 5.02% | 2016-12-30 |
| 515 | 02196 | 复星医药 | Credit Suisse Group AG |
减持 | -437.45万 | 1838.96万 | 4.56% | 2016-12-30 |
| 516 | 02196 | 复星医药 | Credit Suisse Group AG |
增持 | 344.22万 | 2541.88万 | 6.30% | 2016-12-14 |
| 517 | 02196 | 复星医药 | Credit Suisse Group AG |
增持 | 345.27万 | 2325.96万 | 5.77% | 2016-12-14 |
| 518 | 02196 | 复星医药 | Credit Suisse Group AG |
增持 | 242.26万 | 2209.71万 | 5.48% | 2016-12-09 |
| 519 | 02196 | 复星医药 | EARNEST Partners, LLC |
增持 | 318.65万 | 2067.35万 | 5.13% | 2016-12-05 |
| 520 | 02196 | 复星医药 | Wellington Management Group LLP |
增持 | 132.60万 | 2066.19万 | 5.12% | 2016-11-01 |
| 521 | 02196 | 复星医药 | The Capital Group Companies, Inc. |
减持 | -209.20万 | 5047.80万 | 12.52% | 2016-10-14 |
| 522 | 02196 | 复星医药 | The Capital Group Companies, Inc. |
增持 | 36.00万 | 5257.90万 | 13.04% | 2016-09-26 |
| 523 | 02196 | 复星医药 | The Capital Group Companies, Inc. |
减持 | -18.20万 | 5238.00万 | 12.99% | 2016-09-22 |
| 524 | 02196 | 复星医药 | Fosun Holdings Limited |
增持 | 125.00万 | 92620.53万 | 48.47% | 2016-08-31 |
| 525 | 02196 | 复星医药 | Shanghai Fosun High Technology (Group) Co., Ltd. |
增持 | 125.00万 | 92620.53万 | 48.47% | 2016-08-31 |
| 526 | 02196 | 复星医药 | Fosun International Limited |
增持 | 125.00万 | 92620.53万 | 48.47% | 2016-08-31 |
| 527 | 02196 | 复星医药 | Fosun International Holdings Ltd. |
增持 | 125.00万 | 92620.53万 | 48.47% | 2016-08-31 |
| 528 | 02196 | 复星医药 | Fosun Holdings Limited |
增持 | 150.20万 | 92495.53万 | 48.41% | 2016-08-29 |
| 529 | 02196 | 复星医药 | Fosun International Limited |
增持 | 150.20万 | 92495.53万 | 48.41% | 2016-08-29 |
| 530 | 02196 | 复星医药 | Shanghai Fosun High Technology (Group) Co., Ltd. |
增持 | 150.20万 | 92495.53万 | 48.41% | 2016-08-29 |
| 531 | 02196 | 复星医药 | Fosun International Holdings Ltd. |
增持 | 150.20万 | 92495.53万 | 48.41% | 2016-08-29 |
| 532 | 02196 | 复星医药 | JPMorgan Chase & Co. |
减持 | -69.89万 | 1972.73万 | 4.89% | 2016-08-09 |
| 533 | 02196 | 复星医药 | BlackRock, Inc. |
减持 | -77.95万 | 1997.12万 | 4.95% | 2016-07-29 |
| 534 | 02196 | 复星医药 | JPMorgan Chase & Co. |
减持 | -25.47万 | 2403.98万 | 5.96% | 2016-07-29 |
| 535 | 02196 | 复星医药 | The Capital Group Companies, Inc. |
增持 | 168.15万 | 5320.75万 | 13.19% | 2016-07-20 |
| 536 | 02196 | 复星医药 | BlackRock, Inc. |
增持 | 68.66万 | 2077.62万 | 5.15% | 2016-07-11 |
| 537 | 02196 | 复星医药 | BlackRock, Inc. |
减持 | -11.79万 | 2008.96万 | 4.98% | 2016-07-08 |
| 538 | 02196 | 复星医药 | BlackRock, Inc. |
增持 | 16.90万 | 2020.75万 | 5.01% | 2016-07-07 |
| 539 | 02196 | 复星医药 | JPMorgan Chase & Co. |
减持 | -99.94万 | 2782.92万 | 6.90% | 2016-07-06 |
| 540 | 02196 | 复星医药 | JPMorgan Chase & Co. |
减持 | -52.05万 | 3226.27万 | 7.99% | 2016-06-28 |
| 541 | 02196 | 复星医药 | JPMorgan Chase & Co. |
增持 | 131.53万 | 3289.66万 | 8.15% | 2016-06-15 |
| 542 | 02196 | 复星医药 | JPMorgan Chase & Co. |
增持 | 20.90万 | 2826.97万 | 7.00% | 2016-04-18 |
| 543 | 02196 | 复星医药 | JPMorgan Chase & Co. |
增持 | 84.85万 | 2420.34万 | 6.00% | 2016-02-19 |
| 544 | 02196 | 复星医药 | Fosun Holdings Limited |
增持 | 281.19万 | 92345.33万 | 48.33% | 2016-01-28 |
| 545 | 02196 | 复星医药 | Fosun International Holdings Ltd. |
增持 | 281.19万 | 92345.33万 | 48.33% | 2016-01-28 |
| 546 | 02196 | 复星医药 | Fosun International Limited |
增持 | 281.19万 | 92345.33万 | 48.33% | 2016-01-28 |
| 547 | 02196 | 复星医药 | Shanghai Fosun High Technology (Group) Co., Ltd. |
增持 | 281.19万 | 92345.33万 | 48.33% | 2016-01-28 |
| 548 | 02196 | 复星医药 | JPMorgan Chase & Co. |
减持 | -328.55万 | 2361.19万 | 5.85% | 2016-01-21 |
| 549 | 02196 | 复星医药 | JPMorgan Chase & Co. |
减持 | -677.50万 | 2738.22万 | 6.78% | 2015-12-16 |
| 550 | 02196 | 复星医药 | The Capital Group Companies, Inc. |
增持 | 15.45万 | 4846.50万 | 12.02% | 2015-11-26 |